ARRY
Price
$5.20Alerts
Change
+$0.47 (+9.94%)
Updated
Nov 11 closing price
Capitalization
901.72M
111 days until earnings call
Intraday BUY SELL Signals
PASG
Price
$4.00Alerts
Change
+$0.22 (+5.82%)
Updated
Nov 11 closing price
Capitalization
12.79M
116 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARRY vs PASG

ARRY vs PASG Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARRY vs. PASG commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Hold and PASG is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ARRY with price predictions
Nov 11, 2026

Momentum Indicator for ARRY turns positive, indicating new upward trend

ARRY saw its Momentum Indicator move above the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 75 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ARRY just turned positive on October 27, 2026. Looking at past instances where ARRY's MACD turned positive, the stock continued to rise in 31 of 41 cases over the following month. The odds of a continued upward trend are 76%.

ARRY moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ARRY crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 63%.

Following a +40.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARRY advanced for three days, in 191 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The 10-day RSI Indicator for ARRY moved out of overbought territory on November 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In 19 of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 47 cases where ARRY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

ARRY broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ARRY entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.462) is normal, around the industry mean (2.537). P/E Ratio (-6.099) is within average values for comparable stocks, (6.086). Projected Growth (PEG Ratio) (0.399) is also within normal values, averaging (1.699). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (0.543) is also within normal values, averaging (5.133).

The Tickeron PE Growth Rating for this company is 43 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. ARRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.

A.I.Advisor
a Summary for PASG with price predictions
Nov 11, 2026

PASG's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for PASG turned positive on October 29, 2026. Looking at past instances where PASG's MACD turned positive, the stock continued to rise in 48 of 49 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PASG's RSI Indicator exited the oversold zone, 28 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 61 of 68 cases where PASG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on PASG as a result. In 89 of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

Following a +7.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where PASG advanced for three days, in 172 of 212 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PASG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

PASG broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PASG entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. PASG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.870) is normal, around the industry mean (3.498). P/E Ratio (-0.351) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PASG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
ARRY vs PASG: Fundamental Ratings
ARRY
PASG
OUTLOOK RATING
1..100
2621
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5963
P/E GROWTH RATING
1..100
4399
SEASONALITY SCORE
1..100
5031

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRY's Valuation (8) in the Biotechnology industry is somewhat better than the same rating for PASG (68) in the null industry. This means that ARRY’s stock grew somewhat faster than PASG’s over the last 12 months.

ARRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PASG (100) in the null industry. This means that ARRY’s stock grew similarly to PASG’s over the last 12 months.

PASG's SMR Rating (99) in the null industry is in the same range as ARRY (100) in the Biotechnology industry. This means that PASG’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's Price Growth Rating (59) in the Biotechnology industry is in the same range as PASG (63) in the null industry. This means that ARRY’s stock grew similarly to PASG’s over the last 12 months.

ARRY's P/E Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for PASG (99) in the null industry. This means that ARRY’s stock grew somewhat faster than PASG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYPASG
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ARRY: $5.20 vs. PASG: $3.78)
Brand notoriety: ARRY and PASG are both not notable
ARRY represents the Alternative Power Generation, while PASG is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARRY: 98% vs. PASG: 162%
Market capitalization -- ARRY: $901.72M vs. PASG: $12.79M
ARRY [@Alternative Power Generation] is valued at $901.72M. PASG’s [@Biotechnology] market capitalization is $12.79M. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $3.39K to $270.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Alternative Power Generation] industry is $6.02B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRY’s FA Score shows that 1 FA rating(s) are green while PASG’s FA Score has 0 green FA rating(s).

  • ARRY’s FA Score: 1 green, 4 red.
  • PASG’s FA Score: 0 green, 5 red.
According to our system of comparison, ARRY is a better buy in the long-term than PASG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while PASG’s TA Score has 5 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 5 bearish.
  • PASG’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PASG is a better buy in the short-term than ARRY.

Price Growth

ARRY (@Alternative Power Generation) experienced а -2.44% price change this week, while PASG (@Biotechnology) price change was +11.18% for the same time period.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was -5.07%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -44.38%.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.

Reported Earning Dates

ARRY is expected to report earnings on Mar 03, 2027.

PASG is expected to report earnings on Mar 08, 2027.

Industries' Descriptions

@Alternative Power Generation (-5.07% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ARRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARRY has been closely correlated with NXT. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARRY jumps, then NXT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
+9.94%
NXT - ARRY
67%
Closely correlated
+0.77%
SHLS - ARRY
63%
Loosely correlated
+8.24%
AXON - ARRY
53%
Loosely correlated
+4.26%
INO - ARRY
52%
Loosely correlated
+1.72%
ADPT - ARRY
50%
Loosely correlated
+1.98%
More

PASG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PASG has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PASG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PASG
1D Price
Change %
PASG100%
+5.82%
AXON - PASG
43%
Loosely correlated
+4.26%
CYTK - PASG
38%
Loosely correlated
+4.18%
ARRY - PASG
35%
Loosely correlated
+9.94%
QTTB - PASG
34%
Loosely correlated
-1.39%
LXEO - PASG
32%
Poorly correlated
+0.33%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMSI2.350.14
+6.33%
Smith Micro Software Inc
RMD238.534.42
+1.89%
ResMed
SNDX9.590.10
+1.05%
Syndax Pharmaceuticals
TAC13.390.03
+0.22%
TransAlta Corp
YSG1.92-0.01
-0.52%
Yatsen Holding Limited